ArticleBMJ open2023

Multicentre, randomised, double-blind, placebo-controlled phase II study of prophylactic olanzapine for patients with metastatic breast cancer receiving T-DXd treatment: protocol for the ERICA study (WJOG14320B).

Hitomi Sakai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.